Idorsia Ltd (IDIA.SW)

CHF 1.3

(2.45%)

Inventory Summary of Idorsia Ltd

  • Idorsia Ltd's latest annual inventory in 2023 was 59.14 Million CHF , up 65.03% from previous year.
  • Idorsia Ltd's latest quarterly inventory in 2024 Q3 was 67.19 Million CHF , up 1.21% from previous quarter.
  • Idorsia Ltd reported annual inventory of 35.84 Million CHF in 2022, up 65.03% from previous year.
  • Idorsia Ltd reported annual inventory of 21.71 Million CHF in 2021, up 68.41% from previous year.
  • Idorsia Ltd reported quarterly inventory of 59.3 Million CHF for 2024 Q1, up 0.27% from previous quarter.
  • Idorsia Ltd reported quarterly inventory of 67.19 Million CHF for 2024 Q3, up 1.21% from previous quarter.

Annual Inventory Chart of Idorsia Ltd (2023 - 2016)

Historical Annual Inventory of Idorsia Ltd (2023 - 2016)

Year Inventory Inventory Growth
2023 59.14 Million CHF 65.03%
2022 35.84 Million CHF 65.03%
2021 21.71 Million CHF 68.41%
2020 12.89 Million CHF -27.12%
2019 17.69 Million CHF 66.44%
2018 10.63 Million CHF 145.75%
2017 -23.23 Million CHF 0.0%
2016 - CHF 0.0%

Peer Inventory Comparison of Idorsia Ltd

Name Inventory Inventory Difference
Addex Therapeutics Ltd - CHF -Infinity%
BB Biotech AG -2.63 Billion CHF 102.243%
Basilea Pharmaceutica AG 26.41 Million CHF -123.953%
Evolva Holding SA - CHF -Infinity%
Kuros Biosciences AG 4.85 Million CHF -1117.998%
Molecular Partners AG - CHF -Infinity%
Relief Therapeutics Holding AG 557 Thousand CHF -10518.671%
Santhera Pharmaceuticals Holding AG 1.81 Million CHF -3165.93%